☆ 4.6 Editorial Material

Commentary: Does biologic treatment of psoriasis lower the risk of cardiovascular events and mortality? A critical question that we are only just beginning to answer

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Volume 79, Issue 1, Pages 69-70

Publisher

MOSBY-ELSEVIER

DOI: 10.1016/j.jaad.2018.03.046

Keywords

biologic; cardiovascular; mortality; myocardial infarction; psoriasis; stroke; TNF inhibitor

Funding

National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24-AR064310]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Commentary: Does biologic treatment of psoriasis lower the risk of cardiovascular events and mortality? A critical question that we are only just beginning to answer

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Publisher

MOSBY-ELSEVIER

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Commentary: Does biologic treatment of psoriasis lower the risk of cardiovascular events and mortality? A critical question that we are only just beginning to answer

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Publisher

MOSBY-ELSEVIER

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper